China Reform Health Management and Services Group Co., Ltd. Logo

China Reform Health Management and Services Group Co., Ltd.

000503.SZ

(0.8)
Stock Price

11,96 CNY

-3.9% ROA

-5.71% ROE

-148.37x PER

Market Cap.

10.033.067.701,00 CNY

19.9% DER

0% Yield

-18.46% NPM

China Reform Health Management and Services Group Co., Ltd. Stock Analysis

China Reform Health Management and Services Group Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

China Reform Health Management and Services Group Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (31%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (196) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

3 ROE

The stock's ROE indicates a negative return (-11.71%) on shareholders' equity, suggesting poor financial performance.

4 ROA

The stock's ROA (-8.68%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 PBV

The stock's high Price-to-Book Value (P/BV) ratio (20.89x) suggests it's overvalued, potentially making it an expensive investment.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

10 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

China Reform Health Management and Services Group Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

China Reform Health Management and Services Group Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

China Reform Health Management and Services Group Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

China Reform Health Management and Services Group Co., Ltd. Revenue
Year Revenue Growth
1991 112.499.907
1992 93.290.667 -20.59%
1993 74.957.110 -24.46%
1994 82.684.973 9.35%
1995 132.628.767 37.66%
1996 99.798.605 -32.9%
1997 176.378.599 43.42%
1998 221.166.210 20.25%
1999 295.375.142 25.12%
2000 422.881.748 30.15%
2001 339.651.353 -24.5%
2002 342.121.188 0.72%
2003 390.043.997 12.29%
2004 374.991.519 -4.01%
2005 256.372.948 -46.27%
2006 201.724.369 -27.09%
2007 208.301.909 3.16%
2008 286.651.351 27.33%
2009 272.498.437 -5.19%
2010 197.766.773 -37.79%
2011 162.850.417 -21.44%
2012 192.936.834 15.59%
2013 205.906.598 6.3%
2014 195.071.369 -5.55%
2015 193.827.322 -0.64%
2016 216.833.347 10.61%
2017 183.993.714 -17.85%
2018 95.480.022 -92.7%
2019 129.912.815 26.5%
2020 207.372.157 37.35%
2021 252.515.004 17.88%
2022 311.079.455 18.83%
2023 243.156.944 -27.93%
2023 330.126.718 26.34%
2024 357.911.352 7.76%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

China Reform Health Management and Services Group Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
1991 0
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 6.400.972 100%
2012 4.895.943 -30.74%
2013 4.262.116 -14.87%
2014 3.201.801 -33.12%
2015 3.914.907 18.22%
2016 10.478.269 62.64%
2017 18.233.903 42.53%
2018 865.258 -2007.34%
2019 5.794.995 85.07%
2020 16.417.271 64.7%
2021 16.309.111 -0.66%
2022 9.649.308 -69.02%
2023 0 0%
2023 967.945 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

China Reform Health Management and Services Group Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
1991 0
1992 6.839.308 100%
1993 3.808.113 -79.6%
1994 12.626.375 69.84%
1995 17.175.848 26.49%
1996 11.007.963 -56.03%
1997 31.445.074 64.99%
1998 16.685.315 -88.46%
1999 25.024.512 33.32%
2000 25.737.012 2.77%
2001 31.720.893 18.86%
2002 49.942.277 36.48%
2003 81.312.435 38.58%
2004 116.813.143 30.39%
2005 171.773.636 32%
2006 160.426.751 -7.07%
2007 122.910.340 -30.52%
2008 141.406.810 13.08%
2009 140.143.232 -0.9%
2010 116.790.577 -20%
2011 59.771.008 -95.4%
2012 54.223.093 -10.23%
2013 51.396.421 -5.5%
2014 51.625.223 0.44%
2015 42.013.694 -22.88%
2016 54.912.445 23.49%
2017 38.885.423 -41.22%
2018 20.062.264 -93.82%
2019 23.107.754 13.18%
2020 16.652.782 -38.76%
2021 25.379.715 34.39%
2022 20.219.647 -25.52%
2023 300.030.315 93.26%
2023 32.268.597 -829.79%
2024 -52.644.445 161.3%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

China Reform Health Management and Services Group Co., Ltd. EBITDA
Year EBITDA Growth
1991 112.499.907
1992 11.512.847 -877.17%
1993 1.524.787 -655.05%
1994 -7.816.394 119.51%
1995 -22.378.333 65.07%
1996 -4.536.147 -393.33%
1997 -50.711.892 91.06%
1998 21.072.616 340.65%
1999 73.661.453 71.39%
2000 149.253.495 50.65%
2001 163.013.429 8.44%
2002 147.383.729 -10.6%
2003 152.349.497 3.26%
2004 436.249.905 65.08%
2005 105.822.810 -312.25%
2006 60.521.293 -74.85%
2007 67.828.645 10.77%
2008 94.752.267 28.41%
2009 76.297.736 -24.19%
2010 76.695.091 0.52%
2011 86.842.148 11.68%
2012 59.668.325 -45.54%
2013 58.193.380 -2.53%
2014 74.764.905 22.16%
2015 105.588.626 29.19%
2016 52.409.756 -101.47%
2017 100.209.935 47.7%
2018 -134.224.239 174.66%
2019 73.566.529 282.45%
2020 -110.783.472 166.41%
2021 -111.898.469 1%
2022 -65.696.068 -70.33%
2023 -92.528.321 29%
2023 -55.652.970 -66.26%
2024 -109.260.696 49.06%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

China Reform Health Management and Services Group Co., Ltd. Gross Profit
Year Gross Profit Growth
1991 112.499.907
1992 31.709.523 -254.78%
1993 12.954.286 -144.78%
1994 5.666.406 -128.62%
1995 713.570 -694.09%
1996 12.282.233 94.19%
1997 -13.733.019 189.44%
1998 13.998.116 198.11%
1999 73.180.204 80.87%
2000 152.667.960 52.07%
2001 174.639.380 12.58%
2002 208.715.887 16.33%
2003 188.726.081 -10.59%
2004 160.919.668 -17.28%
2005 98.573.993 -63.25%
2006 113.459.354 13.12%
2007 144.298.590 21.37%
2008 191.894.715 24.8%
2009 165.011.494 -16.29%
2010 107.257.849 -53.85%
2011 75.101.320 -42.82%
2012 122.742.653 38.81%
2013 118.703.821 -3.4%
2014 94.051.616 -26.21%
2015 83.736.136 -12.32%
2016 69.586.229 -20.33%
2017 3.211.930 -2066.49%
2018 -60.076.787 105.35%
2019 -33.403.295 -79.85%
2020 30.450.559 209.7%
2021 33.829.004 9.99%
2022 64.459.088 47.52%
2023 46.580.848 -38.38%
2023 81.987.348 43.19%
2024 17.936.572 -357.1%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

China Reform Health Management and Services Group Co., Ltd. Net Profit
Year Net Profit Growth
1991 19.264.628
1992 9.251.465 -108.23%
1993 27.794.923 66.72%
1994 46.154.193 39.78%
1995 -23.738.488 294.43%
1996 41.540.838 157.14%
1997 -160.502.229 125.88%
1998 22.259.743 821.04%
1999 82.395.653 72.98%
2000 79.409.982 -3.76%
2001 92.656.062 14.3%
2002 93.877.944 1.3%
2003 86.849.642 -8.09%
2004 358.074.430 75.75%
2005 42.295.874 -746.59%
2006 27.186.575 -55.58%
2007 3.643.717 -646.12%
2008 5.415.876 32.72%
2009 7.916.980 31.59%
2010 12.164.235 34.92%
2011 18.000.706 32.42%
2012 24.094.567 25.29%
2013 12.978.229 -85.65%
2014 24.977.289 48.04%
2015 23.063.388 -8.3%
2016 28.021.185 17.69%
2017 16.674.851 -68.04%
2018 -187.759.869 108.88%
2019 17.427.722 1177.36%
2020 -243.342.239 107.16%
2021 -177.122.348 -37.39%
2022 -84.464.471 -109.7%
2023 -94.369.961 10.5%
2023 -79.791.985 -18.27%
2024 -130.398.825 38.81%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

China Reform Health Management and Services Group Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1991 0
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

China Reform Health Management and Services Group Co., Ltd. Free Cashflow
Year Free Cashflow Growth
1998 -18.984.625
1999 -33.135.041 42.71%
2000 144.893.869 122.87%
2001 -75.921.438 290.85%
2002 12.567.492 704.11%
2003 -22.548.997 155.73%
2004 -196.269.427 88.51%
2005 -48.491.248 -304.75%
2006 -58.952.933 17.75%
2007 -103.922.783 43.27%
2008 -42.749.090 -143.1%
2009 28.400.552 250.52%
2010 -15.706.718 280.82%
2011 66.222.142 123.72%
2012 26.438.719 -150.47%
2013 117.533.566 77.51%
2014 -69.146.382 269.98%
2015 -63.132.460 -9.53%
2016 -86.749.028 27.22%
2017 -334.669.082 74.08%
2018 -60.713.276 -451.23%
2019 33.500.290 281.23%
2020 -110.707.204 130.26%
2021 -127.948.967 13.48%
2022 -197.866.305 35.34%
2023 -55.435.239 -256.93%
2023 -154.282.694 64.07%
2024 -29.252.267 -427.42%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

China Reform Health Management and Services Group Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
1998 -18.280.527
1999 -29.072.190 37.12%
2000 222.542.142 113.06%
2001 1.063.827 -20819.02%
2002 50.006.754 97.87%
2003 217.840.644 77.04%
2004 53.396.229 -307.97%
2005 -19.366.799 375.71%
2006 -34.840.048 44.41%
2007 -28.533.906 -22.1%
2008 -15.381.230 -85.51%
2009 41.558.260 137.01%
2010 -10.452.028 497.61%
2011 72.376.786 114.44%
2012 65.869.118 -9.88%
2013 159.587.254 58.73%
2014 -24.808.052 743.29%
2015 13.410.825 284.99%
2016 22.942.530 41.55%
2017 -241.511.541 109.5%
2018 -23.181.186 -941.84%
2019 66.044.106 135.1%
2020 -93.006.323 171.01%
2021 -104.821.324 11.27%
2022 -160.204.210 34.57%
2023 -41.114.143 -289.66%
2023 -102.215.068 59.78%
2024 -18.717.292 -446.1%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

China Reform Health Management and Services Group Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
1998 704.099
1999 4.062.850 82.67%
2000 77.648.272 94.77%
2001 76.985.265 -0.86%
2002 37.439.262 -105.63%
2003 240.389.641 84.43%
2004 249.665.656 3.72%
2005 29.124.449 -757.24%
2006 24.112.885 -20.78%
2007 75.388.877 68.02%
2008 27.367.861 -175.47%
2009 13.157.708 -108%
2010 5.254.690 -150.4%
2011 6.154.643 14.62%
2012 39.430.399 84.39%
2013 42.053.687 6.24%
2014 44.338.330 5.15%
2015 76.543.285 42.07%
2016 109.691.558 30.22%
2017 93.157.542 -17.75%
2018 37.532.090 -148.21%
2019 32.543.815 -15.33%
2020 17.700.882 -83.85%
2021 23.127.643 23.46%
2022 37.662.095 38.59%
2023 14.321.096 -162.98%
2023 52.067.627 72.5%
2024 10.534.975 -394.24%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

China Reform Health Management and Services Group Co., Ltd. Equity
Year Equity Growth
1992 102.442.262
1993 338.882.495 69.77%
1994 375.239.376 9.69%
1995 377.231.187 0.53%
1996 418.776.273 9.92%
1997 258.036.741 -62.29%
1998 308.501.888 16.36%
1999 382.066.717 19.25%
2000 506.554.338 24.58%
2001 463.890.917 -9.2%
2002 568.217.534 18.36%
2003 1.091.165.890 47.93%
2004 1.445.902.330 24.53%
2005 1.433.954.323 -0.83%
2006 1.411.595.055 -1.58%
2007 1.365.698.420 -3.36%
2008 1.318.569.313 -3.57%
2009 1.310.867.794 -0.59%
2010 1.295.270.221 -1.2%
2011 1.260.823.520 -2.73%
2012 1.288.909.077 2.18%
2013 1.272.324.517 -1.3%
2014 1.328.200.267 4.21%
2015 1.379.954.970 3.75%
2016 1.413.177.168 2.35%
2017 1.392.914.210 -1.45%
2018 1.217.616.672 -14.4%
2019 1.227.483.904 0.8%
2020 964.217.128 -27.3%
2021 787.226.624 -22.48%
2022 712.988.936 -10.41%
2023 607.086.833 -17.44%
2023 1.421.344.337 57.29%
2024 1.348.965.874 -5.37%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

China Reform Health Management and Services Group Co., Ltd. Assets
Year Assets Growth
1992 142.258.481
1993 452.658.413 68.57%
1994 669.844.447 32.42%
1995 588.116.034 -13.9%
1996 790.787.420 25.63%
1997 615.020.750 -28.58%
1998 730.777.917 15.84%
1999 764.296.525 4.39%
2000 967.103.642 20.97%
2001 936.814.567 -3.23%
2002 1.026.024.020 8.69%
2003 1.539.913.194 33.37%
2004 1.818.197.008 15.31%
2005 1.819.825.715 0.09%
2006 1.769.450.117 -2.85%
2007 1.640.635.118 -7.85%
2008 1.632.199.686 -0.52%
2009 1.623.946.128 -0.51%
2010 1.554.773.179 -4.45%
2011 1.419.662.058 -9.52%
2012 1.478.465.008 3.98%
2013 1.428.044.342 -3.53%
2014 1.434.935.617 0.48%
2015 1.481.815.750 3.16%
2016 1.492.269.915 0.7%
2017 1.448.558.143 -3.02%
2018 1.280.351.320 -13.14%
2019 1.305.210.581 1.9%
2020 1.296.817.917 -0.65%
2021 1.192.309.580 -8.77%
2022 1.104.696.713 -7.93%
2023 1.052.356.629 -4.97%
2023 1.951.543.466 46.08%
2024 1.925.119.352 -1.37%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

China Reform Health Management and Services Group Co., Ltd. Liabilities
Year Liabilities Growth
1992 39.816.218
1993 113.775.917 65%
1994 294.605.071 61.38%
1995 210.884.846 -39.7%
1996 372.011.145 43.31%
1997 356.984.008 -4.21%
1998 422.276.028 15.46%
1999 382.229.807 -10.48%
2000 460.549.303 17.01%
2001 472.923.650 2.62%
2002 457.806.485 -3.3%
2003 448.747.303 -2.02%
2004 372.294.677 -20.54%
2005 385.871.391 3.52%
2006 357.855.062 -7.83%
2007 274.936.697 -30.16%
2008 313.630.372 12.34%
2009 313.078.333 -0.18%
2010 259.502.957 -20.65%
2011 158.838.537 -63.38%
2012 189.555.930 16.2%
2013 155.719.825 -21.73%
2014 106.735.349 -45.89%
2015 101.860.779 -4.79%
2016 79.092.746 -28.79%
2017 55.643.932 -42.14%
2018 62.734.647 11.3%
2019 77.726.675 19.29%
2020 332.600.788 76.63%
2021 405.082.955 17.89%
2022 391.707.776 -3.41%
2023 445.269.796 12.03%
2023 530.199.127 16.02%
2024 576.153.477 7.98%

China Reform Health Management and Services Group Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.37
Net Income per Share
-0.07
Price to Earning Ratio
-148.37x
Price To Sales Ratio
27.31x
POCF Ratio
-94.9
PFCF Ratio
-62.19
Price to Book Ratio
7.47
EV to Sales
25.73
EV Over EBITDA
-126.46
EV to Operating CashFlow
-89.15
EV to FreeCashFlow
-58.6
Earnings Yield
-0.01
FreeCashFlow Yield
-0.02
Market Cap
10,03 Bil.
Enterprise Value
9,45 Bil.
Graham Number
1.46
Graham NetNet
0.93

Income Statement Metrics

Net Income per Share
-0.07
Income Quality
1.56
ROE
-0.06
Return On Assets
-0.04
Return On Capital Employed
-0.05
Net Income per EBT
1.01
EBT Per Ebit
0.94
Ebit per Revenue
-0.2
Effective Tax Rate
-0.02

Margins

Sales, General, & Administrative to Revenue
0.09
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
-0.01
Gross Profit Margin
0.23
Operating Profit Margin
-0.2
Pretax Profit Margin
-0.18
Net Profit Margin
-0.18

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
-0.1
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.11
Free CashFlow per Share
-0.16
Capex to Operating CashFlow
-0.52
Capex to Revenue
0.15
Capex to Depreciation
1.19
Return on Invested Capital
-0.05
Return on Tangible Assets
-0.04
Days Sales Outstanding
241.29
Days Payables Outstanding
67.66
Days of Inventory on Hand
10.12
Receivables Turnover
1.51
Payables Turnover
5.39
Inventory Turnover
36.07
Capex per Share
0.06

Balance Sheet

Cash per Share
1,33
Book Value per Share
1,38
Tangible Book Value per Share
1.19
Shareholders Equity per Share
1.38
Interest Debt per Share
0.28
Debt to Equity
0.2
Debt to Assets
0.14
Net Debt to EBITDA
7.76
Current Ratio
2.7
Tangible Asset Value
1,16 Bil.
Net Current Asset Value
0,98 Bil.
Invested Capital
1175209189
Working Capital
0,98 Bil.
Intangibles to Total Assets
0.1
Average Receivables
0,24 Bil.
Average Payables
0,04 Bil.
Average Inventory
5872708
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

China Reform Health Management and Services Group Co., Ltd. Dividends
Year Dividends Growth
2001 0
2004 0 0%

China Reform Health Management and Services Group Co., Ltd. Profile

About China Reform Health Management and Services Group Co., Ltd.

China Reform Health Management and Services Group Co., Ltd. offers medical insurance management services in China. It is involved in business that covers 177 medical insurance in 25 provinces. It is also involved in the pharmaceutical and medical business. The company was formerly known as SeaRainbow Holding Corp. and changed its name to China Reform Health Management and Services Group Co., Ltd. in May 2018. China Reform Health Management and Services Group Co., Ltd. was founded in 1986 and is based in Haikou, China.

CEO
Mr. Yonghua Li
Employee
1.420
Address
JunHuaHaiYi Hotel
Haikou, 570105

China Reform Health Management and Services Group Co., Ltd. Executives & BODs

China Reform Health Management and Services Group Co., Ltd. Executives & BODs
# Name Age
1 Mr. Zhongsheng Wang
Chief Legal Counsel & Chief Compliance Officer
70
2 Ms. Liqun Sun
Deputy General Manager
70
3 Mr. Wenchang Wang
Chief Accountant
70
4 Mr. Hongquan Yuan
Deputy General Manager
70
5 Mr. Yonghua Li
GM & Director
70
6 Mr. Xinxing Liu
Board Secretary
70
7 Mr. Yingjie Liu
Deputy GM & Director
70
8 Mr. Dicao Sun
Deputy GM & Non-Independent Director
70

China Reform Health Management and Services Group Co., Ltd. Competitors